Friday, 20 November 2026•সত্য • তথ্য • মানুষের কথা
LIVEআজকের গুরুত্বপূর্ণ খবর
✎ সংবাদ দিন
● সর্বশেষ খবর
News

Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s – CNBC

October 2, 2026 • 4:06 pm • masumbilla97.info@gmail.com
Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s – CNBC

Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s  CNBCExperimental Lilly combination drug tops Zepbound in weight-loss trial  reuters.com‘Godzilla’ of weight-loss drugs could provide other important health benefits  The GuardianBlockbuster retatrutide trial signals a ‘new high-water mark’ for weight-loss drugs  Scientific AmericanLilly’s Next-Gen Obesity Drug Helps People Lose Even More Weight in Study  WSJ

সূত্র: মূল সংবাদসূত্র

⌂
হোম
⌕
সার্চ
▣
নিউজ